Lead

An ABC investigation has revealed that unapproved peptides are readily accessible in Australia through social media platforms and wellness clinics, raising concerns about public health and regulatory oversight. The investigation, conducted by the Australian public broadcaster, involved coordinated purchases and undercover consultations to demonstrate the ease with which these substances can be obtained.

Coverage Comparison

The ABC's reporting spans two distinct investigations into the peptide market in Australia. The first focuses on the direct sale of unapproved peptides via social media, particularly Facebook Marketplace, while the second examines the role of wellness and longevity clinics in prescribing these substances. Both reports highlight gaps in regulation and enforcement, but they approach the issue from different angles: one emphasizes the ease of purchase, the other the exploitation of regulatory loopholes by healthcare providers.

The first investigation, detailed in an ABC News report, describes a coordinated deal in which a dealer sold a vial of peptides and a syringe for $50. The report notes that the peptides, including melonatan II and retatrutide, have not been approved for use in Australia but are widely used for weight loss, muscle growth, anti-aging, and skin improvement. The second, presented by ABC's Four Corners program, identifies around 100 operators in Australia offering anti-aging services, with some clinics prescribing unapproved peptides after a consultation.

Key Claims

  • Unregulated peptides are being sold in Australia via social media, with sellers using Facebook Marketplace and other platforms to advertise and distribute them.
  • These peptides have not been approved for use in Australia and have not been assessed for safety, quality, and effectiveness.
  • The peptides can cause serious adverse effects, including liver damage, severe allergic reactions, inflammation, and have been linked to more severe conditions such as cancer and diabetes.
  • Australia's medicine regulator has warned against their use.
  • Wellness and longevity clinics are prescribing unapproved peptides, with doctors taking advantage of gaps in regulation and enforcement.

Perspectives

Australian Public Broadcaster

The ABC's investigation frames the sale and prescription of unapproved peptides as a regulatory failure, emphasizing the risks to consumers and the ease with which these substances can be obtained. The reports quote experts and officials who express concern over the lack of oversight.

Australia Post

Australia Post, mentioned in the ABC report, stated that the sending of illicit items is prohibited and that it works closely with law enforcement, including Australian Border Force, to support detection operations.

Queensland Network of Alcohol and other Drug Agencies

Rebecca Lang, chief executive of the Queensland Network of Alcohol and other Drug Agencies, expressed concern about the trend, noting the difficulty of policing the influx of packages containing such substances.